TY - JOUR T1 - Treatment outcomes of endometrial cancer patients with paraaortic lymph node metastasis: a multi-institutional analysis JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 94 LP - 101 DO - 10.1136/ijgc-2018-000029 VL - 29 IS - 1 AU - Cem Onal AU - Berna Akkus Yildirim AU - Sezin Yuce Sari AU - Guler Yavas AU - Melis Gultekin AU - Ozan Cem Guler AU - Ferah Yildiz AU - Serap Akyurek Y1 - 2019/01/01 UR - http://ijgc.bmj.com/content/29/1/94.abstract N2 - Objective To analyze the prognostic factors and treatment outcomes in endometrial cancer patients with paraaortic lymph node metastasis.Methods Data from four centers were collected retrospectively for 92 patients with endometrial cancer treated with combined radiotherapy and chemotherapy or adjuvant radiotherapy alone postoperatively, delivered by either the sandwich or sequential method. Prognostic factors affecting overall survival and progression-free survival were analyzed.Results The 5-year overall survival and progression-free survival rates were 35 % and 33 %, respectively, after a median follow-up time of 33 months. The 5-year overall survival and progression-free survival rates were significantly higher in patients receiving radiotherapy and chemotherapy postoperatively compared with patients treated with adjuvant radiotherapy alone (P < 0.001 and P < 0.001, respectively). In a subgroup analysis of patients treated with adjuvant combined chemotherapy and radiotherapy, the 5-year overall survival and progression-free survival rates were significantly higher in patients receiving chemotherapy and radiotherapy via the sandwich method compared with patients treated with sequential chemotherapy and radiotherapy (P = 0.02 and P = 0.03, respectively). In the univariate analysis, in addition to treatment strategy, pathology, depth of myometrial invasion, and tumor grade were significant prognostic factors for both overall survival and progression-free survival. In the multivariate analysis, grade III disease, myometrial invasion greater than or equal to 50%, and adjuvant radiotherapy alone were negative predictors for both overall survival and progression-free survival.Conclusion We demonstrated that adjuvant combined treatment including radiotherapyand chemotherapy significantly increases overall survival and progression-free survival rates compared with postoperative pelvic and paraaortic radiotherapy. ER -